Let-7a inhibits growth and migration of breast cancer cells by targeting HMGA1
Tóm tắt
Từ khóa
Tài liệu tham khảo
Gonzalez-Angulo, 2007, Overview of resistance to systemic therapy in patients with breast cancer, Adv Exp Med Biol, 608, 1, 10.1007/978-0-387-74039-3_1
Lv, 2010, The role of survivin in diagnosis, prognosis and treatment of breast cancer, J Thorac Dis, 2, 100
Ambros, 2001, microRNAs: Tiny regulators with great potential, Cell, 107, 823, 10.1016/S0092-8674(01)00616-X
de Moor, 2005, Mechanisms of translational control by the 3′ UTR in development and differentiation, Semin Cell Dev Biol, 16, 49, 10.1016/j.semcdb.2004.11.007
Lee, 1993, The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14, Cell, 75, 843, 10.1016/0092-8674(93)90529-Y
Iorio, 2005, MicroRNA gene expression deregulation in human breast cancer, Cancer Res, 65, 7065, 10.1158/0008-5472.CAN-05-1783
Croce, 2009, Causes and consequences of microRNA dysregulation in cancer, Nat Rev Genet, 10, 704, 10.1038/nrg2634
Esquela-Kerscher, 2006, Oncomirs - microRNAs with a role in cancer, Nat Rev Cancer, 6, 259, 10.1038/nrc1840
Blenkiron, 2007, MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype, Genome Biol, 8, R214, 10.1186/gb-2007-8-10-r214
Silveri, 2006, MicroRNA involvement in mammary gland development and breast cancer, Reprod Nutr Dev, 46, 549, 10.1051/rnd:2006026
Hui, 2009, Robust global micro-RNA profiling with formalin-fixed paraffin-embedded breast cancer tissues, Lab Invest, 89, 597, 10.1038/labinvest.2009.12
Chen, 2009, Role of miR-143 targeting KRAS in colorectal tumorigenesis, Oncogene, 28, 1385, 10.1038/onc.2008.474
Nicoloso, 2009, MicroRNAs - the micro steering wheel of tumour metastases, Nat Rev Cancer, 9, 293, 10.1038/nrc2619
Hui, 2010, Comprehensive microRNA profiling for head and neck squamous cell carcinomas, Clin Cancer Res, 16, 1129, 10.1158/1078-0432.CCR-09-2166
Gramantieri, 2007, Cyclin G1 is a target of miR-122a, a microRNA frequently downregulated in human hepatocellular carcinoma, Cancer Res, 67, 6092, 10.1158/0008-5472.CAN-06-4607
Hiyoshi, 2009, MicroRNA-21 regulates the proliferation and invasion in esophageal squamous cell carcinoma, Clin Cancer Res, 15, 1915, 10.1158/1078-0432.CCR-08-2545
Ma, 2007, Tumour invasion and metastasis initiated by microRNA-10b in breast cancer, Nature, 449, 682, 10.1038/nature06174
Zhang, 2006, microRNAs exhibit high frequency genomic alterations in human cancer, Proc Natl Acad Sci USA, 103, 9136, 10.1073/pnas.0508889103
Takamizawa, 2004, Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival, Cancer Res, 64, 3753, 10.1158/0008-5472.CAN-04-0637
Reinhart, 2000, The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans, Nature, 403, 901, 10.1038/35002607
Akao, 2006, let-7 microRNA functions as a potential growth suppressor in human colon cancer cells, Biol Pharm Bull, 29, 903, 10.1248/bpb.29.903
Park, 2007, Let-7 prevents early cancer progression by suppressing expression of the embryonic gene HMGA2, Cell Cycle, 6, 2585, 10.4161/cc.6.21.4845
Wong, 2011, MicroRNA let-7 suppresses nasopharyngeal carcinoma cells proliferation through downregulating c-Myc expression, J Cancer Res Clin Oncol, 137, 415, 10.1007/s00432-010-0898-4
He, 2010, The let-7a microRNA protects from growth of lung carcinoma by suppression of K-Ras and c-Myc in nude mice, J Cancer Res Clin Oncol, 136, 1023, 10.1007/s00432-009-0747-5
Long, 2009, Let-7a microRNA functions as a potential tumor suppressor in human laryngeal cancer, Oncol Rep, 22, 1189
Talmadge, 2010, AACR centennial series: the biology of cancer metastasis: historical perspective, Cancer Res, 70, 5649, 10.1158/0008-5472.CAN-10-1040
Valastyan, 2009, MicroRNAs: Crucial multitasking components in the complex circuitry of tumor metastasis, Cell Cycle, 8, 3506, 10.4161/cc.8.21.9802
Li, 2014, miR-720 inhibits tumor invasion and migration in breast cancer by targeting TWIST1, Carcinogenesis, 35, 469, 10.1093/carcin/bgt330
Johnson, 2007, The let-7 microRNA represses cell proliferation pathways in human cells, Cancer Res, 67, 7713, 10.1158/0008-5472.CAN-07-1083
Meng, 2007, The microRNA let-7a modulates interleukin-6-dependent STAT-3 survival signaling in malignant human cholangiocytes, J Biol Chem, 282, 8256, 10.1074/jbc.M607712200
Mayr, 2007, Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation, Science, 315, 1576, 10.1126/science.1137999
Liu, 2012, Hsa-let-7a functions as a tumor suppressor in renal cell carcinoma cell lines by targeting c-myc, Biochem Biophys Res Commun, 417, 371, 10.1016/j.bbrc.2011.11.119
Yang, 2011, Low-level expression of let-7a in gastric cancer and its involvement in tumorigenesis by targeting RAB40C, Carcinogenesis, 32, 713, 10.1093/carcin/bgr035
Wang, 2010, Lethal-7 is down-regulated by the hepatitis B virus x protein and targets signal transducer and activator of transcription 3, J Hepatol, 53, 57, 10.1016/j.jhep.2009.12.043
Sampson, 2007, MicroRNA let-7a downregulates MYC and reverts MYC-induced growth in Burkitt lymphoma cells, Cancer Res, 67, 9762, 10.1158/0008-5472.CAN-07-2462
Peluso, 2010, High-mobility group A (HMGA) proteins and breast cancer, Breast Care (Basel), 5, 81, 10.1159/000297717
Reeves, 2001, HMGI/Y proteins: Flexible regulators of transcription and chromatin structure, Biochim Biophys Acta, 1519, 13, 10.1016/S0167-4781(01)00215-9
Resar, 2010, The high mobility group A1 gene: Transforming inflammatory signals into cancer?, Cancer Res, 70, 436, 10.1158/0008-5472.CAN-09-1212
Dolde, 2002, HMG-I/Y in human breast cancer cell lines, Breast Cancer Res Treat, 71, 181, 10.1023/A:1014444114804
Chiappetta, 2010, HMGA1 protein expression in familial breast carcinoma patients, Eur J Cancer, 46, 332, 10.1016/j.ejca.2009.10.015
Flohr, 2003, High mobility group protein HMGA1 expression in breast cancer reveals a positive correlation with tumour grade, Histol Histopathol, 18, 999
Masciullo, 2003, HMGA1 protein over-expression is a frequent feature of epithelial ovarian carcinomas, Carcinogenesis, 24, 1191, 10.1093/carcin/bgg075
Xu, 2004, The HMG-I oncogene causes highly penetrant, aggressive lymphoid malignancy in transgenic mice and is overexpressed in human leukemia, Cancer Res, 64, 3371, 10.1158/0008-5472.CAN-04-0044
Chiappetta, 2001, High mobility group HMGI(Y) protein expression in human colorectal hyperplastic and neoplastic diseases, Int J Cancer, 91, 147, 10.1002/1097-0215(200002)9999:9999<::AID-IJC1033>3.3.CO;2-M
Abe, 2000, Pancreatic duct cell carcinomas express high levels of high mobility group I(Y) proteins, Cancer Res, 60, 3117
Chiappetta, 1998, Detection of high mobility group I HMGI(Y) protein in the diagnosis of thyroid tumors: HMGI(Y) expression represents a potential diagnostic indicator of carcinoma, Cancer Res, 58, 4193
Hillion, 2009, Upregulation of MMP-2 by HMGA1 promotes transformation in undifferentiated, large-cell lung cancer, Mol Cancer Res, 7, 1803, 10.1158/1541-7786.MCR-08-0336
Tamimi, 1993, Increased expression of high mobility group protein I(Y) in high grade prostatic cancer determined by in situ hybridization, Cancer Res, 53, 5512
Tesfaye, 2007, The high-mobility group A1 gene up-regulates cyclooxygenase 2 expression in uterine tumorigenesis, Cancer Res, 67, 3998, 10.1158/0008-5472.CAN-05-1684
Rho, 2007, High mobility group HMGI(Y) protein expression in head and neck squamous cell carcinoma, Acta Otolaryngol, 127, 76, 10.1080/00016480600740571
Hornstein, 2005, The microRNA miR-196 acts upstream of Hoxb8 and Shh in limb development, Nature, 438, 671, 10.1038/nature04138
Wightman, 1993, Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans, Cell, 75, 855, 10.1016/0092-8674(93)90530-4